vs

Side-by-side financial comparison of AXT INC (AXTI) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

AXT INC is the larger business by last-quarter revenue ($26.9M vs $17.3M, roughly 1.6× Sol-Gel Technologies Ltd.). On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 39.1%).

AXT Inc designs, manufactures and sells high-performance compound semiconductor substrates, including gallium arsenide, indium phosphide and germanium wafers. Its products power optoelectronic and radio frequency devices for global communications, consumer electronics and industrial end markets.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

AXTI vs SLGL — Head-to-Head

Bigger by revenue
AXTI
AXTI
1.6× larger
AXTI
$26.9M
$17.3M
SLGL
Growing faster (revenue YoY)
SLGL
SLGL
+178.6% gap
SLGL
217.7%
39.1%
AXTI

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
AXTI
AXTI
SLGL
SLGL
Revenue
$26.9M
$17.3M
Net Profit
$11.6M
Gross Margin
29.6%
Operating Margin
64.5%
65.1%
Net Margin
67.3%
Revenue YoY
39.1%
217.7%
Net Profit YoY
487.6%
EPS (diluted)
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXTI
AXTI
SLGL
SLGL
Q1 26
$26.9M
Q4 25
$23.0M
Q3 25
$28.0M
Q2 25
$18.0M
$17.3M
Q1 25
$19.4M
Q4 24
$25.1M
Q3 24
$23.6M
Q2 24
$27.9M
$5.4M
Net Profit
AXTI
AXTI
SLGL
SLGL
Q1 26
Q4 25
$-3.5M
Q3 25
$-1.9M
Q2 25
$-7.0M
$11.6M
Q1 25
$-8.8M
Q4 24
$-5.1M
Q3 24
$-2.9M
Q2 24
$-1.5M
$2.0M
Gross Margin
AXTI
AXTI
SLGL
SLGL
Q1 26
29.6%
Q4 25
20.9%
Q3 25
22.3%
Q2 25
8.0%
Q1 25
-6.4%
Q4 24
17.6%
Q3 24
24.0%
Q2 24
27.4%
Operating Margin
AXTI
AXTI
SLGL
SLGL
Q1 26
64.5%
Q4 25
-16.6%
Q3 25
-4.0%
Q2 25
-37.5%
65.1%
Q1 25
-53.1%
Q4 24
-24.6%
Q3 24
-14.4%
Q2 24
-6.8%
29.9%
Net Margin
AXTI
AXTI
SLGL
SLGL
Q1 26
Q4 25
-15.4%
Q3 25
-6.8%
Q2 25
-39.0%
67.3%
Q1 25
-45.5%
Q4 24
-20.3%
Q3 24
-12.4%
Q2 24
-5.4%
36.4%
EPS (diluted)
AXTI
AXTI
SLGL
SLGL
Q1 26
Q4 25
$-0.09
Q3 25
$-0.04
Q2 25
$-0.16
$4.17
Q1 25
$-0.20
Q4 24
$-0.11
Q3 24
$-0.07
Q2 24
$-0.04
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXTI
AXTI
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$107.1M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$298.4M
$31.9M
Total Assets
$444.6M
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXTI
AXTI
SLGL
SLGL
Q1 26
$107.1M
Q4 25
$120.3M
Q3 25
$23.1M
Q2 25
$27.0M
$24.3M
Q1 25
$31.6M
Q4 24
$22.8M
Q3 24
$24.9M
Q2 24
$29.5M
$26.5M
Stockholders' Equity
AXTI
AXTI
SLGL
SLGL
Q1 26
$298.4M
Q4 25
$273.3M
Q3 25
$179.1M
Q2 25
$179.7M
$31.9M
Q1 25
$185.0M
Q4 24
$192.8M
Q3 24
$200.7M
Q2 24
$199.7M
$34.9M
Total Assets
AXTI
AXTI
SLGL
SLGL
Q1 26
$444.6M
Q4 25
$433.8M
Q3 25
$334.0M
Q2 25
$329.0M
$39.3M
Q1 25
$333.5M
Q4 24
$339.3M
Q3 24
$355.6M
Q2 24
$349.4M
$42.0M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons